Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "economics"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"330 - Economics"
dewey-ones:"610 - Medicine & health"
Showing
61
-
80
of
102
Search:
'"economics"'
,
query time: 0.04s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
61
Periodic dental examinations for oral health : a review of clinical effectiveness, cost effectiveness, and guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Preventive Dentistry /
economics
...
”
Read Now
62
Switching from innovator to biosimilar (subsequent entry) infliximab : an updated review of the clinical effectiveness, cost-effectiveness, and guidelines
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Biosimilar Pharmaceuticals /
economics
...
”
Read Now
63
Periodic dental examinations for oral health : a review of clinical effectiveness, cost effectiveness, and guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Preventive Dentistry /
economics
...
”
Read Now
64
Deep brain stimulation for Parkinson's disease : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Lachance, Chantelle
,
Spry, Carolyn
,
MacDougall, Danielle
Published 2018
CADTH
Subjects:
“
...Deep Brain Stimulation /
economics
...
”
Read Now
65
Early biologic treatment versus conventional treatment for the management of Crohn's disease : a review of comparative clinical effectiveness and cost-effectiveness
by
Thompson, Wade
,
Argáez, Charlene
Published 2019
CADTH
Subjects:
“
...Tumor Necrosis Factor Inhibitors /
economics
...
”
Read Now
66
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (Orfadin -- Sobi Canada Inc.) : indication: the treatment of adult and pediatric patients with hereditary tyrosinemi...
Published 2018
CADTH
Subjects:
“
...Nitrobenzoates /
economics
...
”
Read Now
67
CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Oligonucleotides /
economics
...
”
Read Now
68
CADTH Canadian Drug Expert Committee recommendation: Cysteamine delayed-release (Procysbi -- Horizon Pharma Ireland Ltd.) : indication : nephropathic cystinosis
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cystine Depleting Agents /
economics
...
”
Read Now
69
CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Oligonucleotides /
economics
...
”
Read Now
70
Trauma-informed care for adults involved in the correctional system : a review of the clinical effectiveness, cost-effectiveness, and guidelines
by
Williams, D.
,
Frey, Nina
Published 2018
CADTH
Subjects:
“
...Delivery of Health Care /
economics
...
”
Read Now
71
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Dermatologic Agents /
economics
...
”
Read Now
72
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Dermatologic Agents /
economics
...
”
Read Now
73
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (nitisinone tablets -- Cycle Pharmaceuticals Ltd.) : indication : the treatment of adult and pediatric patients with...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Enzyme Inhibitors /
economics
...
”
Read Now
74
CDEC final recommendation: Tiotropium bromide (Spiriva respimat -- Boehringer Ingelheim Canada Ltd.) : indication : chronic obstructive pulmonary disease
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Tiotropium Bromide /
economics
...
”
Read Now
75
CADTH Canadian Drug Expert Committee recommendation: Brexpiprazole (Rexulti - Lundbeck Canada Inc and Otsuka Canada Pharmaceutical Inc.) : indication : treatment of schizophrenia i...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antipsychotic Agents /
economics
...
”
Read Now
76
CDEC final recommendation: Tiotropium bromide (Spiriva respimat -- Boehringer Ingelheim Canada Ltd.) : indication : chronic obstructive pulmonary disease
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Tiotropium Bromide /
economics
...
”
Read Now
77
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (nitisinone tablets -- Cycle Pharmaceuticals Ltd.) : indication : the treatment of adult and pediatric patients with...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Enzyme Inhibitors /
economics
...
”
Read Now
78
Bobath therapy for patients with neurological conditions : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Gray, Casey
,
Ford, Caitlyn
Published 2018
CADTH
Subjects:
“
...Physical Therapy Modalities /
economics
...
”
Read Now
79
CADTH Canadian Drug Expert Committee recommendation: Cladribine (Mavenclad -- EMD Serono) : indication: relapsing-remitting multiple sclerosis
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cladribine /
economics
...
”
Read Now
80
Pharmacoeconomic review report: Tiotropium bromide monohydrate and olodaterol hydrochloride (Inspiolto respimat) for oral inhalation
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Bronchodilator Agents /
economics
...
”
1
2
3
4
5
6
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 330 - Economics
Clear Filter
Classification: 610 - Medicine & health
Year of Publication
From:
To:
Classification
330 - Economics
610 - Medicine & health
140 - Specific philosophical schools
11
700 - The arts; fine & decorative arts
10
600 - Technology
2
100 - Philosophy & psychology
1
Language
English
102
Collection
National Center for Biotechnology Information
102
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
63
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
5
Argáez, Charlene
3
Ho, Chuong
3
Campbell, Kaitryn
2
more ...
Chao, Yi-Sheng
2
Ford, Caitlyn
2
Gray, Casey
2
Kanga, Ismat
2
Visintini, Sarah
2
Young, Calvin
2
Adcock, Lorna
1
Frey, Nina
1
Lachance, Chantelle
1
MacDougall, Danielle
1
Membe, Stephen K.
1
Spry, Carolyn
1
Thompson, Wade
1
Williams, D.
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=4&filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&filter%5B%5D=dewey-ones%3A%22610+-+Medicine+%26+health%22&lookfor=%22economics%22&type=AllFields
Send by Email
×
Loading...